In this page

logo-site-lm-ophta-63be6858c57b7647206043.png

NEW LASER THERAPY
FOR ADVANCED AND END-STAGE GLAUCOMA

Ergonomic and easy to use, Vitra 810™ is versatile infrared laser featuring single spot and subliminal technologies which can be used for multiple treatment purposes.

When used for glaucoma treatments, Vitra 810™ offers a new subthreshold cyclophotocoagulation treatment procedure named SubCyclo®, a very promising laser therapy for advanced and end-stage glaucoma patients.

*Not for sale in the USA

Key Features

  • 810nm infrared wavelength for transscleral treatments
  • SubLiminal® subthreshold mode for tissue sparing treatments
  • Non-destructive SubCyclo® glaucoma laser procedure improving the uveoscleral drainage
  • One laser: Two clinical applications (Glaucoma and Retina treatments)

3 technological advantages of Vitra 810™  

Subthreshold Laser Treatment

SubCyclo® is a non-destructive laser procedure for the treatment of glaucoma.  

Based on the principle of transscleral cyclophotocoagulation, SubCyclo® uses a pulsed 810-nanometre diode laser wavelength stimulating the ciliary body and uveoscleral pathway with low power, resulting in significant intraocular pressure (IOP) reduction.

Learn more
subthreshold-laser-treatment-63a564eab7679344708540.webp

ThermoCyclo Laser Treatment

ThermoCyclo - Transscleral Cyclophotocoagulation (TSCPC), is a destructive laser technique for the treatment of advanced refractory glaucoma. 

The ciliary body is targeted with a continuous wave of 810 nanometre laser energy for a duration long enough to thermally denature tissue, causing reduced aqueous humor production, resulting in a decrease of Intra Ocular Pressure (IOP). 

Learn more
thermocyclo-63bbf0e11468c296294087.webp

Treatment protocol

Always use the appropriately rated safety eyewear when operating a laser. 

Following their clinical research at the Glaucoma Institute, Saint Joseph Hospital, Paris (FRANCE), Drs Nassima BENHATCHI and Yves LACHKAR compiled effective SubCyclo® treatment guidelines and Professor Juan Sampaolesi, Argentina, developped an appropriate Thermocyclo treatment guidelines.

Learn more
treatment-guidelines-63a564eab7ab0779811487.webp
<p>Enhanced software interface</p>

Enhanced software interface

Vitra 810™ provides an intuitive and versatile user interface simplifying glaucoma and retina laser treatments.

Built in a clinically oriented manner, it features 4 different software guided treatment procedures.  An Intuitive LCD touchscreen interface giving full control of laser settings.

3 reasons to choose Vitra 810™  

Take full advantage 
with a wide range of accessories

SubCyclo probe
Laser probes
OR microscope
Laser indirect ophthalmoscope
Slit lamp (Haag Streit type)

Testimonials

Vitra 810™ and SubCyclo® are trademarks of Quantel Medical and Lumibird Medical.
All rights reserved.

Clinical references:
1- Nassima BENHATCHI, MD, Djawed BENSMAIL, MD, Yves LACHKAR, MD. Benefits of SubCyclo laser therapy guided by high-frequency ultrasound biomicroscopy in patients with refractory glaucoma - J Glaucoma. 2019 Jun;28(6):535-539. doi: 0.1097/IJG.0000000000001230.
2- Lutic Irina, Dragne Carmen, Filip Mircea, Filip Andrei, Nicolae Miruna, Moisescu Raluca,
Ungureanu Ileana, Triantafyllidis Grigorios, Antonescu Cristina. Subcyclo laser procedure results in patients with glaucoma. Rom J Ophthalmol. 2018 Oct-Dec;62(4):296-299.
3- Facundo G. Sanchez, Juan C. Peirano-Bonomi, Tomas M. Grippo. Micropulse Transscleral Cyclophotocoagulation: A Hypothesis for the Ideal Parameters - Med Hypothesis Discov Innov Ophthalmol. 2018 Fall;7(3):94-100.
 

Download brochure
Contact Us

This website uses cookies

A cookie is a text file automatically saved on your browser and your hard disk by a website when you visit it. It allows your computer to store various technical data such as number of visits, frequency of exposure to an advertising banner, connection to other sites. It also allows you to personalise future visits to a website by storing your login details, preferences, etc. For more information, consult our cookies policy.